These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29256910)

  • 1. CERAD Neuropsychological Battery-Arabic Version: Regression-Based and Stratified Normative Data and Effects of Demographic Variables on Cognitive Performance in Older Omanis.
    Alobaidy A; Al-Sinawi H; Al-Asmi A; Al-Adawi S; Mohamed Essa M; El-Okl M; Jeyaseelan L; Alsawafi L; Almawali M; Alabri B; Alhamrashdi H
    Cogn Behav Neurol; 2017 Dec; 30(4):150-158. PubMed ID: 29256910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age, education and gender in the Consortium to Establish a Registry for the Alzheimer's Disease (CERAD)-Neuropsychological Assessment Battery for Cantonese-speaking Chinese elders.
    Liu KP; Kuo MC; Tang KC; Chau AW; Ho IH; Kwok MP; Chan WC; Choi RH; Lam NC; Chu MM; Chu LW
    Int Psychogeriatr; 2011 Dec; 23(10):1575-81. PubMed ID: 21729408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
    Stein J; Luppa M; Luck T; Maier W; Wagner M; Daerr M; van den Bussche H; Zimmermann T; Köhler M; Bickel H; Mösch E; Weyerer S; Kaufeler T; Pentzek M; Wiese B; Wollny A; König HH; Riedel-Heller SG
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):84-97. PubMed ID: 22183013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A normative study of total scores of the CERAD neuropsychological assessment battery in an educationally diverse elderly population.
    Han JY; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Choi HJ; Kim SG; Park SY; Kim JW; Youn JC; Jhoo JH; Lee JH; Kim KW; Woo JI; Lee DY
    Int Psychogeriatr; 2014 Nov; 26(11):1897-904. PubMed ID: 25075438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB).
    Mistridis P; Egli SC; Iverson GL; Berres M; Willmes K; Welsh-Bohmer KA; Monsch AU
    Eur Arch Psychiatry Clin Neurosci; 2015 Aug; 265(5):407-17. PubMed ID: 25555899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CERAD Neuropsychological Test Battery: norms from a Yoruba-speaking Nigerian sample.
    Guruje O; Unverzargt FW; Osuntokun BO; Hendrie HC; Baiyewu O; Ogunniyi A; Hali KS
    West Afr J Med; 1995; 14(1):29-33. PubMed ID: 7626529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations.
    Collie A; Shafiq-Antonacci R; Maruff P; Tyler P; Currie J
    Aust N Z J Psychiatry; 1999 Aug; 33(4):568-75. PubMed ID: 10483853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-, sex-, and education-specific norms for an extended CERAD Neuropsychological Assessment Battery-Results from the population-based LIFE-Adult-Study.
    Luck T; Pabst A; Rodriguez FS; Schroeter ML; Witte V; Hinz A; Mehnert A; Engel C; Loeffler M; Thiery J; Villringer A; Riedel-Heller SG
    Neuropsychology; 2018 May; 32(4):461-475. PubMed ID: 29517259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.
    Welsh KA; Butters N; Mohs RC; Beekly D; Edland S; Fillenbaum G; Heyman A
    Neurology; 1994 Apr; 44(4):609-14. PubMed ID: 8164812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old.
    Beeri MS; Schmeidler J; Sano M; Wang J; Lally R; Grossman H; Silverman JM
    Neurology; 2006 Sep; 67(6):1006-10. PubMed ID: 17000969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A normative study of the CERAD neuropsychological assessment battery in the Korean elderly.
    Lee DY; Lee KU; Lee JH; Kim KW; Jhoo JH; Kim SY; Yoon JC; Woo SI; Ha J; Woo JI
    J Int Neuropsychol Soc; 2004 Jan; 10(1):72-81. PubMed ID: 14751009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years.
    Kirsebom BE; Espenes R; Hessen E; Waterloo K; Johnsen SH; Gundersen E; Botne Sando S; Rolfseng Grøntvedt G; Timón S; Fladby T
    Clin Neuropsychol; 2019; 33(sup1):27-39. PubMed ID: 30849268
    [No Abstract]   [Full Text] [Related]  

  • 14. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease.
    Berres M; Monsch AU; Bernasconi F; Thalmann B; Stähelin HB
    Stud Health Technol Inform; 2000; 77():195-9. PubMed ID: 11187541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CERAD Neuropsychological Assessment Battery Is Sensitive to Alcohol-Related Cognitive Deficiencies in Elderly Patients: A Retrospective Matched Case-Control Study.
    Kaufmann L; Huber S; Mayer D; Moeller K; Marksteiner J
    J Int Neuropsychol Soc; 2018 Apr; 24(4):360-371. PubMed ID: 29103404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
    J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of CERAD neuropsychological battery in elderly Jamaicans.
    Unverzagt FW; Morgan OS; Thesiger CH; Eldemire DA; Luseko J; Pokuri S; Hui SL; Hall KS; Hendrie HC
    J Int Neuropsychol Soc; 1999 Mar; 5(3):255-9. PubMed ID: 10217925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, gender, and education are associated with cognitive performance in an older Israeli sample with type 2 diabetes.
    Guerrero-Berroa E; Ravona-Springer R; Schmeidler J; Silverman JM; Sano M; Koifmann K; Preiss R; Hoffman H; Heymann A; Schnaider Beeri M
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):299-309. PubMed ID: 23925856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Association Between Visual Field Testing and CERAD Neuropsychological Battery in Idiopathic Normal Pressure Hydrocephalus Patients.
    Kemiläinen B; Tiainen S; Rauramaa T; Luikku AJ; Herukka SK; Koivisto A; Hiltunen M; Verdooner S; Johnson K; Chambers M; Kaarniranta K; Leinonen V
    J Alzheimers Dis; 2024; 100(1):247-260. PubMed ID: 38848179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.